Friedrich Bayer
Co-founder 1863Background
Friedrich Bayer (1825-1880) was a dye salesman who partnered with master dyer Johann Friedrich Weskott to establish Farbenfabriken vorm. Friedr. Bayer & Comp. in Barmen, Germany, on August 1, 1863. Bayer brought commercial expertise and market knowledge to the partnership, while Weskott contributed technical dyeing skills. The company initially produced synthetic fuchsine and aniline dyes, capitalizing on the emerging coal-tar chemistry revolution. After Friedrich Bayer's death in 1880, his son Friedrich Bayer Jr. (1851-1920), a chemist who joined the company in 1873, became the driving force behind its scientific expansion and diversification into pharmaceuticals and agricultural chemicals.
Role at Bayer AG
Bayer was founded in 1863 in Barmen (now part of Wuppertal), Germany, by two men whose partnership bridged the gap between pure science and commercial application: Friedrich Bayer, a successful dye merchant, and Johann Friedrich Weskott, a master dyer. The founding of the company occurred during the zenith of the German chemical revolution, a period when the global textile industry was rapidly transitioning from expensive, unreliable natural dyes (derived from plants or insects) to cheap, vibrant, and reliable synthetic dyes derived from coal tar. Bayer and Weskott founded 'Friedr. Bayer et comp.' to manufacture synthetic fuchsine and aniline dyes. The partnership was effective: Bayer managed the aggressive commercial expansion and sales networks, while Weskott oversaw the complex chemical manufacturing processes. The company grew eventually relocating to a facility in Leverkusen, which remains the company's global headquarters today. The foundational pivot that transformed Bayer from a chemical dye manufacturer into a global pharmaceutical titan occurred in the late 19th century. As the dye market became saturated, Bayer's brilliant chemists began researching the medical applications of their chemical compounds. In 1897, a young Bayer chemist named Felix Hoffmann synthesized acetylsalicylic acid into a stable, pure form that could be easily consumed. Recognizing the commercial potential of this new painkiller, Bayer patented the manufacturing process and trademarked the name 'Aspirin' in 1899. Aspirin became the first globally marketed, mass-produced pharmaceutical drug in history, changing the trajectory of the company and establishing Bayer as one of the most powerful scientific institutions in Europe.